Cargando…
Human pancreatic tumour organoid‐derived factors enhance myogenic differentiation
BACKGROUND: Most patients with pancreatic cancer develop cachexia, which is characterized by progressive muscle loss. The mechanisms underlying muscle loss in cancer cachexia remain elusive. Pancreatic tumour organoids are 3D cell culture models that retain key characteristics of the parent tumour....
Autores principales: | Vaes, Rianne D.W., van Dijk, David P.J., Farshadi, Elham Aïda, Olde Damink, Steven W.M., Rensen, Sander S., Langen, Ramon C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977981/ https://www.ncbi.nlm.nih.gov/pubmed/35146962 http://dx.doi.org/10.1002/jcsm.12917 |
Ejemplares similares
-
Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer‐induced cachexia
por: Vaes, Rianne D.W., et al.
Publicado: (2020) -
Chemosensitivity of 3D Pancreatic Cancer Organoids Is Not Affected by Transformation to 2D Culture or Switch to Physiological Culture Medium
por: Gassl, Vincent, et al.
Publicado: (2022) -
Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids
por: Palzer, Julian, et al.
Publicado: (2021) -
Tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer
por: van Dijk, David P.J., et al.
Publicado: (2019) -
Activation of the Complement System in Patients with Cancer Cachexia
por: Deng, Min, et al.
Publicado: (2021)